Summary
Biogen Inc. (BIIB) filed an 8-K on January 30, 2020, primarily to report its financial results for the fourth quarter and full year ended December 31, 2019, through an accompanying press release furnished as Exhibit 99.1. While the 8-K itself doesn't contain detailed financial figures, it directs investors to the press release for comprehensive information regarding the company's operational performance and financial condition. Investors should review the furnished press release (Exhibit 99.1) for specific revenue, earnings per share, and any other key financial metrics for the reported periods. This filing serves as the official notification of Biogen's recent financial performance and any forward-looking statements or business updates that may have been provided in the press release.
Key Highlights
- 1Biogen Inc. announced its Q4 and full-year 2019 financial results via press release.
- 2The press release containing the financial results is furnished as Exhibit 99.1 to the 8-K.
- 3The information is provided under Item 2.02 (Results of Operations and Financial Condition).
- 4This filing primarily serves as notification of the earnings release.
- 5Investors are directed to the press release for specific financial details and performance metrics.
- 6The furnished press release is not deemed 'filed' for purposes of Section 18 of the Exchange Act.